HFCAS OpenIR

浏览/检索结果: 共5条,第1-5条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway 期刊论文
Nature Communications, 2017
作者:  Ma, Xiaoyu;  Wang, Lin;  Huang, De;  Li, Yunyan;  Yang, Dongdong;  Li, Tingting;  Li, Fudong;  Sun, Linchong;  Wei, Haoran;  He, Kun;  Yu, Fazhi;  Zhao, Debiao;  Hu, Lan;  Xing, Songge;  Liu, Zhaoji;  Li, Kui;  Guo, Jing;  Yang, Zhenye;  Pan, Xin;  Li, Ailing;  Shi, Yunyu;  Wang, Junfeng;  Gao, Ping;  Zhang, Huafeng
浏览  |  Adobe PDF(1933Kb)  |  收藏  |  浏览/下载:89/40  |  提交时间:2020/10/22
Polo-like kinase 1 coordinates biosynthesis during cell cycle progression by directly activating pentose phosphate pathway 期刊论文
NATURE COMMUNICATIONS, 2017, 卷号: 8, 期号: 无, 页码: 15
作者:  Ma, Xiaoyu;  Wang, Lin;  Huang, De;  Li, Yunyan;  Yang, Dongdong;  Li, Tingting;  Li, Fudong;  Sun, Linchong;  Wei, Haoran;  He, Kun;  Yu, Fazhi;  Zhao, Debiao;  Hu, Lan;  Xing, Songge;  Liu, Zhaoji;  Li, Kui;  Guo, Jing;  Yang, Zhenye;  Pan, Xin;  Li, Ailing;  Shi, Yunyu;  Wang, Junfeng;  Gao, Ping;  Zhang, Huafeng
浏览  |  Adobe PDF(1933Kb)  |  收藏  |  浏览/下载:103/49  |  提交时间:2019/02/28
Biocompatible Chitosan-Carbon Dot Hybrid Nanogels for NIR-Imaging-Guided Synergistic Photothermal-Chemo Therapy 期刊论文
ACS APPLIED MATERIALS & INTERFACES, 2017, 卷号: 9, 期号: 22, 页码: 18639-18649
作者:  Wang, Hui;  Mukherjee, Sumit;  Ji, Jinhui;  Banerjee, Probal;  Chen, Qianwang;  Zhou, Shuiqin
浏览  |  Adobe PDF(9178Kb)  |  收藏  |  浏览/下载:99/64  |  提交时间:2018/05/25
Carbon Dots  Chitosan  Cchns  Responsive Release  Nir Imaging  
Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy 期刊论文
CHINESE JOURNAL OF CANCER RESEARCH, 2017, 卷号: 29
-
收藏  |  浏览/下载:31/0  |  提交时间:2020/10/26
PAINFUL DIABETIC-NEUROPATHY  DOUBLE-BLIND  PLACEBO  PREVENTION  MANAGEMENT  TRIAL  GABAPENTIN  PREGABALIN  ONCOLOGY  TAXANES  Duloxetine  FACT-Tax Scales  paclitaxel  peripheral neuropathy  
Use of liposomal doxorubicin for adjuvant chemotherapy of breast cancer in clinical practice 期刊论文
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2017, 卷号: 18
-
收藏  |  浏览/下载:27/0  |  提交时间:2020/10/26
RANDOMIZED PHASE-III  NEOADJUVANT CHEMOTHERAPY  ENCAPSULATED DOXORUBICIN  1ST-LINE CHEMOTHERAPY  PROGNOSTIC MARKER  PLUS DOCETAXEL  COMBINATION  CYCLOPHOSPHAMIDE  TRASTUZUMAB  PACLITAXEL  Liposomal doxorubicin  Breast cancer  Adjuvant chemotherapy  Therapeutic effect  Toxic and side effects